Skip to content
台杉投資台杉投資
  • About Us
    • Our Mission
    • Board Members
    • Management Team
  • Funds
  • CEE Fund
    • Portfolios
    • FAQ
  • News
  • Insights
  • Portfolio
    • Portfolio
    • Update
  • Training
  • 中 | EN

Update

AI Starup AESOP Raises $3M to Tackle Medical and Billing Errors

2022 年 9 月 1 日

Point Robotics’ Surgical Robot Is Taiwan’s First FDA-Cleared

2022 年 8 月 24 日

Elixiron Immunotherapeutics Receives Grant From the Alzheimer’s Association to Trial Microglia-Targeting Immunotherapy

2022 年 7 月 18 日

Nanolive SA Announces Initial Closing of Series C-1 Round

2022 年 4 月 4 日

CISION: FIGUR8 and Parker Hannifin Quick Coupling Division Partner to Improve Musculoskeletal Health in the Workplace

2022 年 3 月 1 日

CISION: Windgap Medical, Inc. Closes Over $39 Million of Series B-1 Investment More Than Twenty Percent Over Its Initial Goal

2022 年 1 月 21 日

Congratulations to both of our portfolios, Ambiq and Arris, win the 2022 BIG Innovation Award

2022 年 1 月 14 日

businesswire:Appaegis is Helping Companies Secure Access to Applications and Data with a Flash Round of Funding

2021 年 12 月 20 日
頁面1 頁面2 頁面3 頁面4 頁面5 頁面6
  • 110208台北市信義區基隆路一段333號18樓1806室
  • TEL:+886 2 2720 9898
  • FAX:+886 2 2720 0686
  • Taiwania Capital Management USA, Inc 3945 Freedom Circle, Suite 760, Santa Clara, CA 95054
Envelope Facebook-f Linkedin-in Youtube Podcast

Copyright © Taiwania Capital. All rights reserved.

  • 繁體中文 | English
  • About Us
    • Our Mission
    • Board Members
    • Management Team
  • Funds
  • CEE Fund
    • Portfolios
    • FAQ
  • News
  • Insights
  • Portfolio
    • Portfolio
    • Update
  • Training